BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17322632)

  • 21. Is soluble CD40 ligand a mediator of angiogenesis in patients with coronary artery disease?
    Lim HS; Tayebjee MH; Tan KT; Patel JV; Macfadyen RJ; Lip GY
    Thromb Res; 2008; 122(3):307-13. PubMed ID: 18054068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating angiopoietins-1 and -2, angiopoietin receptor Tie-2 and vascular endothelial growth factor-A as biomarkers of acute myocardial infarction: a prospective nested case-control study.
    Iribarren C; Phelps BH; Darbinian JA; McCluskey ER; Quesenberry CP; Hytopoulos E; Vogelman JH; Orentreich N
    BMC Cardiovasc Disord; 2011 Jun; 11():31. PubMed ID: 21672190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum endostatin in the coronary circulation of patients with coronary heart disease and its relation to coronary collateral formation.
    Mitsuma W; Kodama M; Hanawa H; Ito M; Ramadan MM; Hirono S; Obata H; Okada S; Sanada F; Yanagawa T; Kashimura T; Fuse K; Tanabe N; Aizawa Y
    Am J Cardiol; 2007 Feb; 99(4):494-8. PubMed ID: 17293192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of serum calprotectin, angiopoietin‑1, and angiopoietin‑2 levels with coronary collateral circulation in patients with stable coronary artery disease.
    Demir V; Ede H; Ercan M; Turan Y; Hidayet S; Inandiklioglu N; Erbay AR
    Kardiol Pol; 2019 Dec; 77(12):1155-1162. PubMed ID: 31617500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between thrombospondin-1, endostatin, angiopoietin-2, and coronary collateral development in patients with chronic total occlusion.
    Qin Q; Qian J; Ma J; Ge L; Ge J
    Medicine (Baltimore); 2016 Aug; 95(33):e4524. PubMed ID: 27537575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reciprocal regulation of angiopoietin-1 and angiopoietin-2 following myocardial infarction in the rat.
    Sandhu R; Teichert-Kuliszewska K; Nag S; Proteau G; Robb MJ; Campbell AI; Kuliszewski MA; Kutryk MJ; Stewart DJ
    Cardiovasc Res; 2004 Oct; 64(1):115-24. PubMed ID: 15364619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.
    Mohan JS; Lip PL; Blann AD; Bareford D; Lip GY
    Br J Ophthalmol; 2005 Jul; 89(7):815-9. PubMed ID: 15965157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of angiogenic molecules in autoimmune thyroid diseases and their correlation with laboratory and clinical features.
    Figueroa-Vega N; Sanz-Cameno P; Moreno-Otero R; Sánchez-Madrid F; González-Amaro R; Marazuela M
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1145-53. PubMed ID: 19141578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating Angiopoietin-2 and Its Soluble Receptor Tie-2 Concentrations Are Related to Renal Function in Two Population-Based Cohorts.
    Hennings A; Hannemann A; Rettig R; Dörr M; Nauck M; Völzke H; Lerch MM; Lieb W; Friedrich N
    PLoS One; 2016; 11(11):e0166492. PubMed ID: 27893762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correlation of angiopoietin-2 and angiopoietin-2 receptor expressions in serum and placenta with preeclampsia].
    Wang LJ; Chen WP; Peng W; Xu L; Sui AH; Ye YH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):167-71. PubMed ID: 21575447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiopoietin-2 as a Prognostic Factor in Patients with Incurable Stage IV Colorectal Cancer.
    Munakata S; Ueyama T; Ishihara H; Komiyama H; Tsukamoto R; Kawai M; Takahashi M; Kojima Y; Tomiki Y; Sakamoto K
    J Gastrointest Cancer; 2021 Mar; 52(1):237-242. PubMed ID: 32166589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Percutaneous Coronary Intervention on Serum Angiopoietin-2 in Patients with Coronary Heart Disease.
    Zeng ZY; Gui C; Li L; Wei XM
    Chin Med J (Engl); 2016 Mar; 129(6):631-5. PubMed ID: 26960364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of biomarkers of endothelial activation in predicting morbidity and mortality in patients with severe sepsis and septic shock in intensive care: A prospective observational study.
    Fang Y; Li C; Shao R; Yu H; Zhang Q
    Thromb Res; 2018 Nov; 171():149-154. PubMed ID: 30312800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship with clinical course and prognosis of serum endothelin-1, angiopoietin-2, and tie-2 levels in Crimean-Congo hemorrhagic fever.
    Kerget F; Özkurt Z; Öztürk N; Yılmaz S
    Turk J Med Sci; 2019 Aug; 49(4):1192-1197. PubMed ID: 31293143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating biomarkers of angiogenesis as indicators of left ventricular systolic dysfunction amongst patients with coronary artery disease.
    Patel JV; Abraheem A; Chackathayil J; Gunning M; Creamer J; Hughes EA; Lip GY
    J Intern Med; 2009 May; 265(5):562-7. PubMed ID: 19187100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating angiopopietin-1 correlates with the clinical course of multiple organ dysfunction syndrome and mortality in patients with severe sepsis.
    Lin SM; Chung FT; Kuo CH; Chou PC; Wang TY; Chang PJ; Lo YL; Huang CD; Lin HC; Wang CH; Kuo HP
    Medicine (Baltimore); 2015 May; 94(20):e878. PubMed ID: 25997069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of plasma soluble Tie-2 level to distinguish moyamoya disease from atherosclerotic cerebrovascular disease and predict postoperative neovascularization.
    Chen T; Wei W; Zhang J; Yu J; Xu S; Wu D; Li X; Chen J
    J Neurosurg; 2023 Dec; 139(6):1705-1714. PubMed ID: 37347656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating angiopoietin-2 is a strong prognostic factor in acute myeloid leukemia.
    Schliemann C; Bieker R; Thoennissen N; Gerss J; Liersch R; Kessler T; Büchner T; Berdel WE; Mesters RM
    Leukemia; 2007 Sep; 21(9):1901-6. PubMed ID: 17597808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic changes in serum angiopoietin-1, angiopoietin-2, and angiopoietin-2/angiopoietin-1 ratio in acute myocardial infarction patients treated with primary percutaneous coronary intervention.
    Chen S; Guo L; Cui M; Sun L; Mi L
    Biomarkers; 2012 Aug; 17(5):441-6. PubMed ID: 22642477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.
    David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT
    Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.